Facts
PublisherScienceDirect
Source TypeReference Work
Reliability Tier2
Sources
Doxil, The First FDA-Approved Nano-Drug: Lessons Learned (ScienceDirect)
ScienceDirect
Claims Backed By This Source (3 claims)
This source backs 3 claims across the atlas. As facts: 3 well-attested.
Disposition By Topic
- Sources, 3 claims: 3 well-attested.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.